Health Dupixent® (dupilumab) Late-breaking Phase 3 COPD Results Globe News Wire May 22, 2023 Dupixent is the first and only investigational biologic for COPD…
Tech Asthma and COPD Drug Market Size Growing at 5.2% CAGR Set Globe News Wire Mar 17, 2023 <!-- Name:DistributionId Value:8790565 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…